Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness - Trial NCT06292052
Access comprehensive clinical trial information for NCT06292052 through Pure Global AI's free database. This phase not specified trial is sponsored by Sun Yat-sen University and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 350 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Sun Yat-sen University
Timeline & Enrollment
N/A
Jan 01, 2017
Apr 01, 2024
Primary Outcome
Complete pathologic response
Summary
The goal of this retrospective cohort analysis is to discover the impact of the involvement
 extent of tumor-draining lymph nodes (TDLNs) in patients who received neoadjuvant
 immunochemotherapy. The main question it aims to answer is the role of TDLN in the prediction
 of treatment effectiveness. Researches will compare tumor-draining lymph nodes metastasis
 (mTDLNs) group and non-draining lymph nodes metastasis (mNDLNs) group to see whether
 different metastatic patterns of mediastinal lymph nodes can indicate the treatment
 effectiveness.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06292052
Non-Device Trial